1178. The Dalba Diary: A Retrospective Review of Dalbavancin Use, Clinical Outcomes, and Treatment Adherence Challenges at an Academic Medical Center

BACKGROUND: Dalbavancin is FDA-approved for skin and skin tissue infections (SSTI) and is an alternative therapy for deep-seated gram-positive infections when avoidance of long-term catheters or prolonged hospitalization for intravenous (IV) antibiotics is desired. This observational, retrospective...

Descripción completa

Detalles Bibliográficos
Autores principales: Black, Cassandra E, Gregory, Eric, Wilson, Nicole, Shoemaker, D Matthew, Haas, Gabriel Ann, Wark, Kellie, Kimball, Joanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677644/
http://dx.doi.org/10.1093/ofid/ofad500.1018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677644/
http://dx.doi.org/10.1093/ofid/ofad500.1018

Ejemplares similares